Preprint / Version 1

EARLY PREDICTORS OF HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA AT A LEVEL III HOSPITAL. LIMA, PERU.

##article.authors##

  • Dr. Jorge Ravelo-Hernández Hospital Central de la Fuerza Aérea del Perú https://orcid.org/0000-0001-9179-3541
    • Dr. Ursula Cáceres-Bernaola Hospital Central de la Fuerza Aérea del Perú
      • Dr. Claudia Becerra-Nuñez Hospital Central de la Fuerza Aérea del Perú
        • Sabina Mendívil-Tuchia Hospital Central de la Fuerza Aérea del Perú
          • María Eugenia Vásquez-Rivas Hospital Central de la Fuerza Aérea del Perú
            • Wilfor Aguirre-Quispe Hospital Central de la Fuerza Aérea del Perú
              • Edwin Quispe-Ayuque Hospital Central de la Fuerza Aérea del Perú
                • Gabriela Reyes-Rocha Clínica San Juan Bautista, Complejo Hospitalario San Pablo, Lima, Perú

                  DOI:

                  https://doi.org/10.1590/SciELOPreprints.1314

                  Keywords:

                  SARS-CoV-2, COVID-19, Severe acute respiratory syndrome, Viral pneumonia, Coronavirus infections, mortality, spiral computed tomography, Hospitalization

                  Abstract

                  Objective: Determine whether the tomographic characteristics of patients with COVID-19 pneumonia at hospital admission and the initial tomographic severity score (TSS) as well as some laboratory tests or clinical characteristics predict mortality and length of hospital stay.Material and methods: Analytical, retrospective study that included 203 patients with a clinical diagnosis of SARSCoV2 Virus Infection, performed by reverse transcriptase polymerase chain reaction (RT-PCR), reactive serological test (IgM/IgG) and/or spiral computed tomography (CT) chest without contrast, admitted in the period from 6 April to 27 June 2020. Two radiologists (blind evaluators) described the tomographic findings. 15 patients with normal CT were excluded, 188 patients with clinical and laboratory parameters were admitted to the statistical analysis of TSS and mortality; data taken from epidemiological records and clinical histories, divided into two groups: recovered and deceased. Data analysis used the statistical package Stata version 14.2; hospital stay was analyzed by Kaplan – Meier curves and mortality prediction was made by Cox regression with 95% CI and a p value <0.05 as statistically significant.Results: Hypertension was the most frequent associated disease, the most common clinical presentation included cough, malaise, fever and dyspnea , there were no significant differences between studied groups   (Recovered  vs. death patients), 15 cases had normal CT, for this reason, they were excluded from the TSS score and mortality analysis. Mean age of the recovered patients was 53.6 ± 16.4 years and of the deceased 75.9 ± 13.9 years (p <0.0001). A moderate and high TSS (≥ 8) resulted in deaths (p <0.05), as well as a higher degree of lymphopenia and a history of asthma in the deceased (p <0.05). The variable arterial hypertension predicts the increase in days of hospital stay (p <0.05). The ground glass pattern was the most frequent, followed by the consolidation and distortion of the architecture; however, they were not associated with a type of outcome. The pattern of pleural effusion and bronchial dilation showed a significant difference with respect to the outcome, however, but it could be due to the infrequency of presentation of these patterns. Conclusions: TSS is useful in the initial and comprehensive diagnostic evaluation of COVID-19 pneumonia, in conjunction with markers such as lymphopenia and elevated CRP that can predict a poor short-term outcome. A high TSS score is a predictor of mortality. Hypertension predicts the increase in days of hospital stay.

                  Downloads

                  Download data is not yet available.

                  Author Biographies

                  Dr. Jorge Ravelo-Hernández, Hospital Central de la Fuerza Aérea del Perú

                  Physician Assistant from Department of Medicine.Hospital Central de la Fuerza Aérea del Perú

                   

                  Dr. Ursula Cáceres-Bernaola, Hospital Central de la Fuerza Aérea del Perú

                  Physician Assistant from Department of Medicine.Hospital Central de la Fuerza Aérea del Perú

                  Dr. Claudia Becerra-Nuñez, Hospital Central de la Fuerza Aérea del Perú

                  Assistant Physician of the Department of Medicine. Central Hospital of the Peruvian Air Force

                  Sabina Mendívil-Tuchia, Hospital Central de la Fuerza Aérea del Perú

                  Assistant Infectologist Physician, Department of Medicine. Central Hospital of the Peruvian Air Force

                  María Eugenia Vásquez-Rivas, Hospital Central de la Fuerza Aérea del Perú

                  Chief Physician of Clinical Laboratory and Blood Bank, Central Hospital of the Peruvian Air Force

                  Wilfor Aguirre-Quispe, Hospital Central de la Fuerza Aérea del Perú

                  General Medicine Physician, Clinical Epidemiologist, Neurology Resident. National Institute of Neurological Sciences, Lima Peru

                  Edwin Quispe-Ayuque, Hospital Central de la Fuerza Aérea del Perú

                  Radiologist, Imaging Department, Hospital Central Fuerza Aérea del Perú

                  Gabriela Reyes-Rocha , Clínica San Juan Bautista, Complejo Hospitalario San Pablo, Lima, Perú

                  Chief Physician of the Radiology Department, Clínica San Juan Bautista, Complejo Hospitalario San Pablo, Lima, Peru

                  Submitted

                  10/07/2020

                  Posted

                  10/13/2020

                  How to Cite

                  EARLY PREDICTORS OF HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA AT A LEVEL III HOSPITAL. LIMA, PERU. (2020). In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.1314

                  Section

                  Health Sciences

                  Plaudit